Concepedia

Publication | Open Access

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy

DOIFull Paper Access

792

Citations

12

References

2006

Year

Tarek A Yousry, Eugene O. Major, Caroline F. Ryschkewitsch, Gary A. Fahle, Steven H. Fischer, Jean Hou, Blanche Curfman, Katherine Miszkiel, Nicole Mueller‐Lenke, Esther Sánchez,
New England Journal of Medicine

Abstract

A detailed review of possible cases of PML in patients exposed to natalizumab found no new cases and suggested a risk of PML of roughly 1 in 1000 patients treated with natalizumab for a mean of 17.9 months. The risk associated with longer treatment is not known.

References

YearCitations

Page 1